Our pipeline

Image of pipettes with pink liquid

We've played an instrumental role in bringing 11 new cancer drugs to market. Now, we're continuing to fast-track scientific breakthroughs into patient benefit through our pioneering research.

Our robust and sustainable pipeline spans early stage discovery through to clinical trials and beyond with 15 drugs currently in phase II/III trials and nearly 50 partnered agents in pre-clinical and clinical development.